Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says By Reuters – Investing.com
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi (NASDAQ:SNY) and U.S. group Translate Bio (NASDAQ:TBIO) “will not be ready this year,” the French drugmaker’s chief executive told Le Journal du Dimanche newspaper.
Clinical trials of this vaccine, which will be based on a technology known as mRNA — on which lean approved vaccines of Pfizer/BioNTech and Moderna (NASDAQ:MRNA) –, are expected to start this quarter.
In December last year, Sanofi had said it was targeting “earliest…
-
Noosa News21 hours agoMitch Power Quick Shear event gets men talking about mental health
-
Noosa News22 hours agoReport into Queensland CFMEU branch leaves many questions unanswered
-
General22 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News15 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs